Drugs / laniquidar
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00028873 | Sep 2001 → Jun 2002 | breast cancer | European Organisation for Research and Treatment of Cancer - EORTC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | laniquidar | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00028873 ↗ |
| Modality | Small molecule | — CHEMBL539378 ↗ |